Effect of ciltacabtagene autoleucel versus standard-of-care on patient-reported outcomes in the CARTITUDE-4 trial of patients with lenalidomide-refractory multiple myeloma after 1-3 prior lines of therapy Meeting Abstract


Authors: Gries, K.; Tran, L.; Appenfeller, A.; Folkers, A.; Florendo, E.; Mina, R.
Abstract Title: Effect of ciltacabtagene autoleucel versus standard-of-care on patient-reported outcomes in the CARTITUDE-4 trial of patients with lenalidomide-refractory multiple myeloma after 1-3 prior lines of therapy
Meeting Title: 49th Annual Congress of the Oncology Nursing Society (ONS)
Journal Title: Oncology Nursing Forum
Volume: 51
Issue: 2
Meeting Dates: 2024 Apr 24-28
Meeting Location: Washington, DC
ISSN: 0190-535X
Publisher: Oncology Nursing Society (ONS)  
Date Published: 2024-03-01
Start Page: 14
End Page: 15
Language: English
ACCESSION: WOS:001349389400117
PROVIDER: wos
DOI: 10.1188/24.ONF.E3
Notes: Meeting Abstract: I28 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Linh Tran
    5 Tran